|
|
|
| Qualified eSignature in Electronic Consent Systems | A Primer for Clinical Trial Professionals
Electronic consent (eConsent) systems have proven to add value to patients, sponsors, and sites. However, varying regulations across regions and countries can impact implementation of eConsent solutions and dilute the benefits. Join us and delve into global regulatory scenarios and options for meeting eSignature requirements and learn what to look for in eConsent solutions to ensure you’re prepared for every trial. Learn more. |
|
|
|
|
|
| Are You Paying Participants Enough? Your Top Questions Answered | Article | By Sam Whitaker, Mural Health and Kelly Fitzgerald, WCG | Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics. |
|
|
|
| How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials | Guest Column | A conversation with Moupali Das, MD, MPH, Gilead Sciences | VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection. |
|
|
|
| Obesity Clinical Research: Patient Recruitment Challenges | Article | By Joanna Pulawska, Ph.D. and Nicole Zandy, IQVIA Biotech | Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines. |
|
|
|
|
| Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites | Guest Column | A conversation with Jimmy Bechtel, MBA, Society for Clinical Research Sites (SCRS) and Ken Getz, MBA, Tufts Center for the Study of Drug Development (CSDD) | Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD. |
|
|
| Developing Community-Based And Trial-Naïve Sites: The Real ROI | Article | By Catherine Jervis, MRN - Medical Research Network | Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment. |
|
|
|
| How Community-Based Research Models Expand Access | Article | By Miranda McLaren, EmVenio Clinical Research | As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's? |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
